Orchestra BioMed Holdings (OBIO) Change in Account Payables (2021 - 2022)
Orchestra BioMed Holdings' (OBIO) quarterly Change in Account Payables came in at $95369.0 in Q4 2022, up 35818.73% year-on-year from N/an in Q4 2021, and down 14.01% on a QoQ basis from $110904.0 in Q3 2022.
Orchestra BioMed Holdings (OBIO) Change in Account Payables (2021 - 2022) Analysis & Trends
Orchestra BioMed Holdings (OBIO) has 2 years of Change in Account Payables data on file, last reported at $95369.0 in Q4 2022.
- On a quarterly basis, Change in Account Payables rose 35818.73% year-over-year to $95369.0 in Q4 2022; TTM through Dec 2022 was $375542.0, a 3123.2% increase from a year earlier, with the FY2022 full-year figure at $375542.0, up 3123.2% from the prior year.
- Change in Account Payables for Q4 2022 stood at $95369.0, down from $110904.0 in the prior quarter.
- Over the last five years, Change in Account Payables for OBIO reached as high as $110904.0 in Q3 2022 and fell as low as -$17680.0 in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Orchestra BioMed Holdings | 228.31 Mn | 143.68 Mn | 78,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 95,369.00 |
| Dec 31, 2022 | 95,369.00 |
| Sep 30, 2022 | 110,904.00 |
| Sep 30, 2022 | 110,904.00 |
| Jun 30, 2022 | 67,050.00 |
| Jun 30, 2022 | 67,050.00 |
| Mar 31, 2022 | 102,219.00 |
| Mar 31, 2022 | 102,219.00 |
| Dec 31, 2021 | -267.00 |
| Dec 31, 2021 | -267.00 |
| Sep 30, 2021 | -17,680.00 |
| Sep 30, 2021 | -17,680.00 |
| Jun 30, 2021 | -15,225.00 |
| Jun 30, 2021 | -15,225.00 |
| Mar 31, 2021 | 20,750.00 |
| Mar 31, 2021 | 20,750.00 |